PT - JOURNAL ARTICLE AU - Giuseppe, De Natale AU - Ricciardi, Valerio AU - De Luca, Gabriele AU - De Natale, Dario AU - Di Meglio, Giovanni AU - Ferragamo, Antonio AU - Marchitelli, Vito AU - Piccolo, Andrea AU - Scala, Antonio AU - Somma, Renato AU - Spina, Emanuele AU - Troise, Claudia TI - The COVID-19 infection in Italy: a statistical study of an abnormally severe disease AID - 10.1101/2020.03.28.20046243 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.28.20046243 4099 - http://medrxiv.org/content/early/2020/04/01/2020.03.28.20046243.short 4100 - http://medrxiv.org/content/early/2020/04/01/2020.03.28.20046243.full AB - We statistically investigate the COVID-19 epidemics, which is particularly invasive in Italy. We show that the high apparent mortality (or Case Fatality Ratio, CFR) observed in Italy, as compared with other countries, is likely biased by a strong underestimation of infected cases. To give a more realistic estimate of the mortality of Covid-19, we use the most recent estimates of the IFR (Infection Fatality Ratio) of epidemic, based on CFR for Germany, and furthermore analyse data obtained from the ship ‘Diamond Princess’, a good representation of a ‘laboratory’ case-study from an isolated system in which all the people have been tested. From such analyses we try to derive more realistic estimates of the real extension of the infection, as well as more accurate indicators of how fast the infection propagates. We then try to point out, from the various explanations proposed, the dominant factors causing such an abnormal seriousness of the disease in Italy. Finally, we use the deceased data, the only ones estimated to be reliable enough, to predict the total number of infected people and the interval of time when the infection in Italy could stop.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo supporting fundsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are taken by public datasets, referenced in the paper. They are free to be used for anyone.